NOVARTIS AG (NVSEF)
Clinical trial NCT06247995 updates: 1. completion date: 2031-09-09 → 2027-04-14 2. primary completion date: 2031-09-09 → 2027-04-14
Clinical trial NCT06247995 updates: 1. completion date: 2031-09-09 → 2027-04-14 2. primary completion date: 2031-09-09 → 2027-04-14
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical